881 related articles for article (PubMed ID: 34284151)
1. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
2. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
5. SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer.
Kara G; Ozpolat B
Biomed Microdevices; 2024 Feb; 26(1):16. PubMed ID: 38324228
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
[TBL] [Abstract][Full Text] [Related]
7. Biogenesis of Extracellular Vesicles Produced from Human-Stem-Cell-Derived Cortical Spheroids Exposed to Iron Oxides.
Marzano M; Bou-Dargham MJ; Cone AS; York S; Helsper S; Grant SC; Meckes DG; Sang QA; Li Y
ACS Biomater Sci Eng; 2021 Mar; 7(3):1111-1122. PubMed ID: 33525864
[TBL] [Abstract][Full Text] [Related]
8. Controlled SPION-Exosomes Loaded with Quercetin Preserves Pancreatic Beta Cell Survival and Function in Type 2 Diabetes Mellitus.
Zhuang M; Rao L; Chen Y; Xiao S; Xia H; Yang J; Lv X; Qin D; Zhu C
Int J Nanomedicine; 2023; 18():5733-5748. PubMed ID: 37849640
[TBL] [Abstract][Full Text] [Related]
9. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
10. Assessing the combination of magnetic field stimulation, iron oxide nanoparticles, and aligned electrospun fibers for promoting neurite outgrowth from dorsal root ganglia in vitro.
Funnell JL; Ziemba AM; Nowak JF; Awada H; Prokopiou N; Samuel J; Guari Y; Nottelet B; Gilbert RJ
Acta Biomater; 2021 Sep; 131():302-313. PubMed ID: 34271170
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
[TBL] [Abstract][Full Text] [Related]
12. Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
Esmaeili A; Alini M; Baghaban Eslaminejad M; Hosseini S
Stem Cell Res Ther; 2022 Mar; 13(1):129. PubMed ID: 35346367
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer.
Tyagi N; Gupta P; Khan Z; Neupane YR; Mangla B; Mehra N; Ralli T; Alhalmi A; Ali A; Al Kamaly O; Saleh A; Nasr FA; Kohli K
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903587
[TBL] [Abstract][Full Text] [Related]
14. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives.
Cheng Z; Shang J; Wang H; Yu L; Yuan Z; Zhang Y; Du Y; Tian J
J Control Release; 2023 Oct; 362():97-120. PubMed ID: 37625599
[TBL] [Abstract][Full Text] [Related]
16. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
Lamichhane TN; Jay SM
Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
18. Heparin-Superparamagnetic Iron Oxide Nanoparticles for Theranostic Applications.
Massironi N; Colombo M; Cosentino C; Fiandra L; Mauri M; Kayal Y; Testa F; Torri G; Urso E; Vismara E; Vlodavsky I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296711
[TBL] [Abstract][Full Text] [Related]
19. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
20. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ
J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
